Richard Channick, MD will discuss the importance of looking for and understanding chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH occurs when blood clots block or narrow the blood vessels in the lungs. A potentially surgically reversible form of pulmonary hypertension, it is essential to include screening for CTEPH in the work up of newly diagnosed pulmonary hypertension patients. Join us June 26th to learn more about diagnosing and treating this disease.
At the conclusion of this live activity, attendees will be able to:
Describe the natural history of acute pulmonary embolism
Propose a treatment approach for a patient with chronic thromboembolic pulmonary hypertension.
This live activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education Council for Continuing Medical Education (ACCME) through the joint sponsorship of Washington University School of Medicine, Continuing Medical Education and the Pulmonary Hypertension Association.
Washington University is accredited by the ACCME to provide continuing medical education for physicians.
Washington University designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.